An integrated model of care for inflammatory bowel disease sufferers in Australia: Development and the effects of its implementation

Inflammatory Bowel Diseases

Volumn 18, Issue 8, 2012, Pages 1573-1581

  Mikocka Walus, Antonina A ^a,b   Turnbull, Deborah ^b   Holtmann, Gerald ^b,c   Andrews, Jane M ^b,d  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

biopsychosocial; health systems; inflammatory bowel disease; integrated model of care; mental health; psycho gastroenterology

Indexed keywords

CORTICOSTEROID; DESIPRAMINE; FLUOXETINE; OPIATE;

ANXIETY; ARTICLE; AUSTRALIA; AWARENESS; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; DISEASE ACTIVITY; DISEASE DURATION; DRUG EFFICACY; ENTERITIS; EPIDEMIOLOGICAL DATA; FOLLOW UP; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTEGRATED MODEL OF CARE; MENTAL DISEASE; MENTAL HEALTH; MODEL; OUTPATIENT CARE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; PSYCHOLOGICAL MODEL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; TEACHING HOSPITAL;

AUSTRALIA; DELIVERY OF HEALTH CARE, INTEGRATED; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INFLAMMATORY BOWEL DISEASES; STRESS, PSYCHOLOGICAL;

EID: 84863981179     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.22850     Document Type: Article

References (60)

1. Folks DG, Kinney FC,. The role of psychological factors in gastrointestinal conditions. A review pertinent to DSM-IV. Psychosomatics. 1992; 33: 257-270.
2. Golden J, O'Dwyer AM, Conroy RM,. Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors. Gen Hosp Psychiatry. 2005; 27: 431-438.
3. Härter MC, Conway KP, Merikangas KR,. Associations between anxiety disorders and physical illness. Eur Arch Psychiatry Clin Neurosci. 2003; 253: 313-320.
4. Hillila MT, Siivola MT, Farkkila MA,. Comorbidity and use of health-care services among irritable bowel syndrome sufferers. Scand J Gastroenterol. 2007; 42: 799-806.
5. Mittermaier C, Dejaco C, Waldhoer T, et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med. 2004; 66: 79-84.
6. Rodin G, Craven J, Littlefield C,. Depression in the Medically Ill. An Integrated Approach. New York: Brunner/Mazel; 1991.
7. Jones MP, Dilley JB, Drossman D, et al. Brain-gut connections in functional GI disorders: anatomic and physiologic relationships. Neurogastroenterol Motil. 2006; 18: 91-103.
8. Taché Y,. How the brain stresses the gut: the role of brain CRF. Geneva: World Health Organization; 1999, Contract No. RPC/99.1.
9. Drossman D, Creed F, Olden K, et al. Psychosocial aspects of the functional gastrointestinal disorders. Gut. 1999; 45 (Suppl II): II25-II30.
10. Bitton A, Dobkin P, Edwardes MD, et al. Predicting relapse in Crohn's disease: a biopsychosocial model. Gut. 2008; 57: 1386-1392.
11. Kuchenhoff J,. [Bio-psychosocial interactions in follow-up of Crohn disease.] Z Psychosom Med Psychoanal. 1995; 41: 306-328.
12. Tache Y, Bernstein CN,. Evidence for the role of the brain-gut axis in inflammatory bowel disease: depression as cause and effect? Gastroenterology. 2009; 136: 2058-2061.
13. Addolorato G, Capristo E, Stefanini GF, et al. Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol. 1997; 32: 1013-1021.
14. Bernstein CN, Singh S, Graff LA, et al. A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol. 2010; 105: 1994-2002.
15. Grone O, Garcia-Barbero M,. Integrated care: a position paper of the WHO European Office for Integrated Health Care Services. Int J Integr Care. 2001; 1: e21.
16. Engel GL,. The need for a new medical model: a challenge for biomedicine. Science. 1977; 196: 129-136.
17. Engel GL,. The clinical application of the biopsychosocial model. Am J Psychiatry. 1980; 137: 535-544.
18. Engel GL,. Studies of ulcerative colitis. III. The nature of the psychologic processes. Am J Med. 1955; 19: 231-256.
19. Engel GL,. Studies of ulcerative colitis. IV. The significance of headaches. Psychosom Med. 1956; 18: 334-346.
20. Engel CC, Walker EA, Katon WJ,. Factors related to dissociation among patients with gastrointestinal complaints. J Psychosom Res. 1996; 40: 643-653.
21. Glaser JP, Engel GL,. Psychodynamics, psychophysiology and gastrointestinal symptomatology. Clin Gastroenterol. 1977; 6: 507-531.
22. Drossman DA,. Gastrointestinal illness and the biopsychosocial model. Psychosom Med. 1998; 60: 258-267.
23. Bolibar I, Plaza V, Llauger M, et al. Assessment of a primary and tertiary care integrated management model for chronic obstructive pulmonary disease. BMC Public Health. 2009; 9: 68.
24. de Stampa M, Vedel I, Mauriat C, et al. Diagnostic study, design and implementation of an integrated model of care in France: a bottom-up process with continuous leadership. Int J Integr Care. 2010; 10: e034.
25. Vedel I, De Stampa M, Bergman H, et al. A novel model of integrated care for the elderly: COPA, Coordination of Professional Care for the Elderly. Aging Clin Exp Res. 2009; 21: 414-423.
26. Renders CM, Halberstadt J, Frenkel CS, et al. Tackling the problem of overweight and obesity: the Dutch approach. Obes Facts. 2010; 3: 267-272.
27. Lloyd J, Wait S,. Integrated care: a guide for policy makers. London: Alliance for Health and the Future, 2005. 14 December 2010; Available from
28. Arseneau KO, Yeaton P, Kahaleh M, et al. Effect of digestive health care services integration on resource use and outcomes in patients with digestive disorders. Clin Gastroenterol Hepatol. 2003; 1: 145-151.
29. Gerson CD, Gerson MJ,. A collaborative health care model for the treatment of irritable bowel syndrome. Clin Gastroenterol Hepatol. 2003; 1: 446-452.
30. Bryant RV, van Langenberg DR, Holtmann GJ, et al. Functional gastrointestinal disorders in inflammatory bowel disease: impact on quality of life and psychological status. J Gastroenterol Hepatol. 2011; 26: 916-923.
31. Mikocka-Walus A, Gordon A, Stewart B, et al. A magic pill? A qualitative analysis of patients' views on the role of antidepressants in inflammatory bowel disease (IBD). BMC Gastroenterol. 2011 (submitted).
32. Mikocka-Walus A, Turnbull DA, Andrews JM, et al. The effect of functional gastrointestinal disorders on psychological comorbidity and quality of life in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2008; 28: 475-483.
33. Mikocka-Walus A, Turnbull DA, Moulding NT, et al. "It doesn't do any harm, but patients feel better": a qualitative exploratory study on gastroenterologists' perspectives on the role of antidepressants in inflammatory bowel disease. BMC Gastroenterol. 2007; 7: 38.
34. Mikocka-Walus AA, Turnbull DA, Andrews JM, et al. Psychological problems in gastroenterology outpatients: a South Australian experience. Psychological co-morbidity in IBD, IBS and hepatitis C. Clin Pract Epidemol Ment Health. 2008; 4: 15.
35. van Langenberg DR, Lange K, Hetzel DJ, et al. Adverse clinical phenotype in inflammatory bowel disease: a cross sectional study identifying factors potentially amenable to change. J Gastroenterol Hepatol. 2010; 25: 1250-1258.
36. Mikocka-Walus AA, Turnbull DA, Moulding NT, et al. Does psychological status influence clinical outcomes in patients with inflammatory bowel disease (IBD) and other chronic gastroenterological diseases: an observational cohort prospective study. Biopsychosoc Med. 2008; 2: 11.
37. Mikocka-Walus A, Gordon A, Stewart B, et al. The role of antidepressants in the management of inflammatory bowel disease (IBD): a short report on a clinical case-note audit. J Psychosom Res. 2011 [Epub ahead of print].
38. Mikocka-Walus AA, Turnbull DA, Moulding NT, et al. Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review. Inflamm Bowel Dis. 2007; 13: 225-234.
39. Mikocka-Walus A, Clarke D, Gibson P,. Can antidepressants influence the course of inflammatory bowel disease (IBD)? The current state of research. Eur Gastroenterol Hepatol Rev. 2009; 5: 48-53.
40. Mikocka-Walus A, Turnbull DA, Moulding NT, et al. Antidepressants and inflammatory bowel disease: a systematic review. Clin Pract Epidemol Ment Health. 2006; 2: 24.
41. Mikocka-Walus AA, Turnbull DA, Andrews JM, et al. Does doctors' knowledge of IBD patients' psychological status affect patients' clinical outcomes: a pilot RCT. Eur J Gastroenterol Hepatol. 2009; 21: 484-485.
42. Mikocka-Walus AA, Bond M, Holloway R, et al. Does cognitive-behavioural therapy (CBT) improve outcomes in inflammatory bowel disease (IBD)? Initial feasibility report on a pilot randomised controlled trial. Gastroenterology. 2010; 138: s521-2, Dig Dis Week 2010 presentation T1253.
43. Sack C, Phan VA, Grafton R, et al. A chronic care model significantly decreases costs and healthcare utilization in patients with inflammatory bowel disease. J Crohn's Colitis. 2011 [Epub ahead of print].
44. Van Langenberg DR, Simon SB, Holtmann G, et al. The burden of inpatient costs in inflammatory bowel disease and opportunities to optimise care: a single metropolitan Australian center experience. J Crohn's Colitis. 2010; 4: 413-421.
45. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Helsinki, Finland: World Medical Association; 1964.
46. Rome III. The functional gastrointestinal disorders. Gastroenterology. 2006; 130: 1377-1556.
47. British IBD Standards. Accessed Oct 2010; Available from
48. Mikocka-Walus A, Turnbull D, Andrews JM, et al. Psychogastroenterology: a call for psychological input in Australian gastroenterology clinics. Intern Med J. 2009; 39: 127-130.
49. Schutze A, Kaiser U, Ettrich U, et al. [Evaluation of a multimodal pain therapy at the University Pain Centre Dresden.] Schmerz. 2009; 23: 609-617.
50. Bernstein CN,. New insights into IBD epidemiology: are there any lessons for treatment? Dig Dis. 2010; 28: 406-410.
51. Mawdsley JE, Jenkins DG, Macey MG, et al. The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Am J Gastroenterol. 2008; 103: 1460-1469.
52. Mawdsley JE, Rampton DS,. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut. 2005; 54: 1481-1491.
53. Wahed M, Corser M, Goodhand JR, et al. Does psychological counseling alter the natural history of inflammatory bowel disease? Inflamm Bowel Dis. 2010; 16: 664-669.
54. von Wietersheim J, Kessler H,. Psychotherapy with chronic inflammatory bowel disease patients: a review. Inflamm Bowel Dis. 2006; 12: 1175-1184.
55. Andrews JM, Holtmann G,. IBD: stress causes flares of IBDhow much evidence is enough? Nat Rev Gastroenterol Hepatol. 2011; 8: 13-14.
56. Bee PE, Bower P, Lovell K, et al. Psychotherapy mediated by remote communication technologies: a meta-analytic review. BMC Psychiatry. 2008; 8: 60.
57. Kaltenthaler E, Brazier J, De Nigris E, et al. Computerised cognitive behaviour therapy for depression and anxiety update: a systematic review and economic evaluation. Health Technol Assess. 2006; 10: iii, xi-xiv, 1-168.
58. Ljotsson B, Hedman E, Andersson E, et al. Internet-delivered exposure-based treatment vs. stress management for irritable bowel syndrome: a randomized trial. Am J Gastroenterol. 2011; 106: 1481-1491.
59. Tan M, Holloway RH, Lange K, et al. General practitioners' knowledge of and attitudes to inflammatory bowel disease. Intern Med J. 2001 [Epub ahead of print].
60. Fox S, Chesla C,. Living with chronic illness: a phenomenological study of the health effects of the patient-provider relationship. J Am Acad Nurs Pract. 2008; 20: 109-117.